Metabolic Research
Retatrutide
Retatrutide is a synthetic peptide studied for coordinated activation of three metabolic hormone receptors, with human research examining glucose regulation, appetite, body weight and liver fat.
MGF refers to an IGF-1-related research concept and synthetic E-domain peptides whose proposed independent muscle effects have conflicting experimental support.
Explore the research profileSubmit an unpaid laboratory order request for manual review. Availability and any pending amounts require confirmation.
Catalog quantities are not assay results.
Experimental IGF-1 E-domain peptide
Mechano-growth factor, or MGF, is used ambiguously for an exercise-responsive IGF-1 splice variant and for synthetic peptides modeled on its distinctive E-domain. Human IGF-1Ec transcripts, full-length precursor proteins, mature IGF-1, and isolated E-domain peptides are different entities. Their evidence should not be treated as interchangeable.
This reference describes the published literature. Exact supplied form and chemical specifications require product-specific documentation. The studies are linked in Selected literature.
Early cell experiments proposed that the MGF E-domain promotes myoblast proliferation while delaying differentiation through a pathway distinct from the IGF-1 receptor. A later investigation failed to reproduce these responses across several muscle-cell systems, leaving the proposed independent peptide mechanism disputed.
A 2002 study reported differing effects of the E-domain and mature IGF-1 on myoblast growth and differentiation. PubMed links a 2006 erratum to this paper. Its results are an early hypothesis, not a settled mechanism. [1]
Muscle biopsies from ten men showed changes in IGF-1 isoform expression following an exercise-induced injury protocol. The study also included separate cell experiments. Measuring endogenous expression in people does not demonstrate benefit from administering a synthetic MGF peptide. [3]
A 2014 study tested human and mouse muscle-cell models and found no apparent MGF effect on proliferation or differentiation. Mature IGF-1 produced responses in the same systems, making this a substantive challenge to earlier peptide-specific claims. [2]
Study topics describe the cited models, not established benefits of this catalog material.
The cited human research is an expression study, not a clinical efficacy trial of the isolated peptide. Positive early observations and later negative experiments must be considered together. The literature does not establish that synthetic MGF improves human muscle recovery, strength, or hypertrophy.
Nomenclature, precursor processing, peptide sequence, and experimental system complicate comparisons. Findings about an IGF-1 transcript cannot establish a separately supplied fragment's biological activity. The cited work also does not support extrapolation to modified MGF products, demonstrate long-term human safety, or validate WYZ Labs materials.
Primary studies and clearly identified supporting sources. Each link opens the original record.
Early positive myoblast findings; PubMed records a 2006 erratum.
Independent experiments did not reproduce proposed peptide activity across multiple models.
Ten men underwent muscle-biopsy sampling; synthetic peptide effects were studied separately in cells.
Literature reviewed October 2026. This is a selected research overview, not an exhaustive systematic review. Published findings do not establish the identity, purity, sterility or suitability of any WYZ batch. For laboratory research only; not for human or veterinary use.
Final product specifications and product-specific storage instructions have not been supplied. Review the original documentation and your laboratory’s procedures before obtaining or using the material.
For qualified laboratory researchers. Not for human or veterinary use. Product information is not medical advice or a recommendation for personal use.
What to look for in a COA